Oxford BioMedica PLC (OXB)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

629.00p

Buy

635.00p

arrow-down-15.00p (-2.34%)

Prices updated at 12 Dec 2025, 17:00 GMT

Prices minimum 15 mins delay

Prices in GBX

Oxford BioMedica PLC is a biopharmaceutical company based in the United Kingdom. It develops gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

08 Dec 2025

01 Dec 2025

03 Nov 2025

29 Oct 2025

27 Oct 2025

16 Oct 2025

07 Oct 2025

01 Oct 2025

23 Sep 2025

Key dates

	Forecast date
Half yearly results	Sep 2026
Annual general meeting	Jun 2026
Annual report	Apr 2026
Final results	Apr 2026

	Previous date
Half yearly results	Sep 2025
Annual general meeting	Jun 2025
Annual report	Apr 2025
Final results	Apr 2025

Company reports

31 Dec 2022

Annual Report

30 Jun 2012

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.